Autoimmune Hemolytic Anemia Treatment Market Poised for Significant Growth Through 2035
The global autoimmune hemolytic anemia (AIHA) treatment market is experiencing steady expansion, driven by advances in diagnostic technologies, growing investment in biopharmaceuticals, and increasing awareness of autoimmune conditions. AIHA is a rare disorder in which the immune system mistakenly attacks and destroys red blood cells, leading to anemia. As treatment paradigms shift toward...
0 التعليقات 0 المشاركات 5 مشاهدة 0 معاينة